Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenic HER-2/neu peptides as tumor vaccines.
Baxevanis CN, Sotiriadou NN, Gritzapis AD, Sotiropoulou PA, Perez SA, Cacoullos NT, Papamichail M. Baxevanis CN, et al. Among authors: papamichail m. Cancer Immunol Immunother. 2006 Jan;55(1):85-95. doi: 10.1007/s00262-005-0692-3. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15948002 Free PMC article. Review.
Cancer immunotherapy: perspectives and prospects.
Perez SA, Papamichail M. Perez SA, et al. Among authors: papamichail m. Adv Exp Med Biol. 2008;622:235-53. doi: 10.1007/978-0-387-68969-2_19. Adv Exp Med Biol. 2008. PMID: 18546632 Review. No abstract available.
Cancer immunotherapy.
Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: papamichail m. Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809. Crit Rev Clin Lab Sci. 2009. PMID: 19650714 Free article. Review.
A new era in anticancer peptide vaccines.
Perez SA, von Hofe E, Kallinteris NL, Gritzapis AD, Peoples GE, Papamichail M, Baxevanis CN. Perez SA, et al. Among authors: papamichail m. Cancer. 2010 May 1;116(9):2071-80. doi: 10.1002/cncr.24988. Cancer. 2010. PMID: 20187092 Free article. Review.
Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer.
Perez SA, Kallinteris NL, Bisias S, Tzonis PK, Georgakopoulou K, Varla-Leftherioti M, Papamichail M, Thanos A, von Hofe E, Baxevanis CN. Perez SA, et al. Among authors: papamichail m. Clin Cancer Res. 2010 Jul 1;16(13):3495-506. doi: 10.1158/1078-0432.CCR-10-0085. Epub 2010 May 13. Clin Cancer Res. 2010. PMID: 20466887 Clinical Trial.
HER-2/neu as a target for cancer vaccines.
Baxevanis CN, Voutsas IF, Gritzapis AD, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: papamichail m. Immunotherapy. 2010 Mar;2(2):213-26. doi: 10.2217/imt.09.89. Immunotherapy. 2010. PMID: 20635929 Review.
Developing effective cancer vaccines.
Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: papamichail m. Eur J Cancer. 2011 Sep;47 Suppl 3:S364-5. doi: 10.1016/S0959-8049(11)70205-2. Eur J Cancer. 2011. PMID: 21944017 Review. No abstract available.
205 results